NUTEX HEALTH INC (NUTX)
US67079U2078 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 15.30M | 0.00 | 1.10M | |||
| Cash Equivalents | 22.00M | 34.30M | N/A | N/A | N/A | |||
| Receivables | 62.78M | 58.30M | 2.10M | 0.00 | 100.00K | |||
| Inventories | 3.39M | 3.50M | N/A | 0.00 | 0.00 | |||
| Other Current Assets | 2.68M | 1.90M | 300.00K | 100.00K | 100.00K | |||
| Total Current Assets | 90.85M | 98.00M | 17.70M | 200.00K | 1.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 269.39M | 295.20M | 100.00K | 0.00 | 300.00K | |||
| Investments And Advances | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Goodwill | 17.07M | 17.00M | 57.30M | 0.00 | 3.50M | |||
| Intangibles | 20.51M | 21.20M | 10.60M | 0.00 | 1.50M | |||
| Other Non-Current Assets | 431.14K | 400.00K | N/A | 0.00 | 100.00K | |||
| Total Non-Current Assets | 307.40M | 333.80M | 68.00M | 0.00 | 5.50M | |||
| TOTAL ASSETS | 398.25M | 431.80M | 85.70M | 200.00K | 6.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 3.37M | 2.60M | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 15.12M | 16.80M | 4.60M | 300.00K | 2.50M | |||
| Accrued Expenses | 14.54M | 7.90M | 200.00K | 0.00 | 100.00K | |||
| Accounts Payable | 25.28M | 27.50M | 3.50M | 700.00K | 1.80M | |||
| Other Current Liabilities | N/A | N/A | 300.00K | 100.00K | 300.00K | |||
| Total Current Liabilities | 58.31M | 54.90M | 8.60M | 1.20M | 4.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 240.20M | 226.70M | 200.00K | 200.00K | 0.00 | |||
| Deferred Taxes/Income | 5.15M | 10.50M | 1.70M | N/A | N/A | |||
| Other Non-Current Liabilities | 15.48M | 19.40M | 100.00K | 0.00 | 200.00K | |||
| Total Non-Current Liabilities | 278.48M | 281.00M | 2.00M | 100.00K | 200.00K | |||
| TOTAL LIABILITIES | 336.79M | 335.90M | 10.60M | 1.30M | 4.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -409.07M | -363.30M | -31.90M | -18.20M | -12.60M | |||
| Additional Paid In Capital | 469.85M | 458.50M | 107.00M | 17.10M | 14.40M | |||
| Minority Interest | 15.29M | 32.50M | 0.00 | N/A | N/A | |||
| Common Shares | 676.68K | 700.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 676.68M | 650.20M | 48.20M | 5.30M | 4.60M | |||
| Tangible Book Value per Share | 0.04 | 0.09 | 0.15 | -0.21 | -0.67 | |||
| Total Shareholders' Equity | 61.45M | 95.90M | 75.10M | -1.10M | 1.90M | |||
| TOTAL LIABILITIES AND EQUITY | 398.25M | 431.80M | 85.70M | 200.00K | 6.70M | |||
| Statistics | ||||||||
| Debt/Equity | 3.96 | 2.39 | 0.00 | -0.18 | N/A | |||
| Current Ratio | 1.56 | 1.79 | 2.06 | 0.17 | 0.26 | |||
| Return On Assets (ROA) | -11.50% | -98.38% | -15.99% | -2850.00% | -105.97% | |||
| Return On Equity (ROE) | -74.51% | -442.96% | -18.24% | N/A | -373.68% | |||
All data in USD